LECT2 and Hepatic fibrosis: In conclusion, LECT2 is a novel and direct predictor, which is suitable as a screening biomarker for significant and advanced liver fibrosis, and the diagnostic efficacy of LECT2 in different situations of patients with CHB had been confirmed.